ACTA1 and chronic kidney disease: At the molecular level, pro-fibrotic molecules, such as α-SMA, vimentin, and fibroblast-specific protein-1 (FSP-1), presented similar patterns in the kidneys of BMMC-treated animals, suggesting a protective role of BMMCs in attenuating the AKI-CKD transition [86].